dc.contributor.author | Christianty, Fransiska Maria | |
dc.contributor.author | Suharjono, Suharjono | |
dc.contributor.author | Susilo, Imam | |
dc.contributor.author | Khotib, Junaidi | |
dc.date.accessioned | 2019-11-29T07:09:32Z | |
dc.date.available | 2019-11-29T07:09:32Z | |
dc.date.issued | 2019-08-01 | |
dc.identifier.uri | http://repository.unej.ac.id//handle/123456789/96503 | |
dc.description.abstract | Endothelial dysfunction has been considered as one of the key initial events in the pathogenesis
of atherosclerosis and other cardiovascular diseases (CVDs). Several studies imply that chronic
inflammation and oxidative stress play a critical role in endothelial dysfunction. The present study
was designed to evaluate the preventive effect of alpha-lipoic acid (ALA) on lipopolysaccharide
(LPS) induced endothelial dysfunction in rat based on malondialdehyde (MDA) level and vascular
cell adhesion molecules-1 (VCAM-1) expression. Pretreatment with
ALA for 14 days could decrease plasma MDA level on LPS-induced endothelial dysfunction in rats.
However, only one group of ALA doses, 120 mg.kg
-1
BW, showed significant difference with LPS
untreated group statistically. It was also found that ALA, in all treatment groups, could attenuate
VCAM-1 expression. These findings suggest that ALA had a protective effect against endothelial
dysfunction and may potentially prevent vascular inflammatory disease. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pharmaceutical Sciences and Research (PSR), 6(2), Agustus 2019 | en_US |
dc.subject | alpha lipoic acid | en_US |
dc.subject | lipopolysaccharide | en_US |
dc.subject | endothelial dysfunction | en_US |
dc.subject | MDA | en_US |
dc.subject | VCAM-1 | en_US |
dc.title | Preventive Effects of Alpha-Lipoic Acid on Lipopolysaccharide-Induced Endothelial Dysfunction in Rats | en_US |
dc.type | Article | en_US |
dc.identifier.kodeprodi | KODEPRODI2210101#Farmasi | |
dc.identifier.nidn | NIDN0006048405 | |